Comparison of rapid steroid elimination with basiliximab induction vs standard immunosuppression (MMF, tacrolimus and steroids) in recipients of live-donor renal allografts.

被引：0
|
作者：
Campos, L [1 ]
Weiland, AM [1 ]
Philosophe, B [1 ]
Schweitzer, EJ [1 ]
Foster, CE [1 ]
Bartlett, ST [1 ]
机构：
[1] Univ Maryland, Dept Surg, Baltimore, MD 21201 USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2004年 / 4卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
709
引用
收藏
页码：351 / 351
页数：1
相关论文
共 13 条
  • [1] RENAL ALLOGRAFT OUTCOMES IN LIVE DONOR RECIPIENTS ON TACROLIMUS BASED TRIPLE IMMUNOSUPPRESSION WITH AND WITHOUT BASILIXIMAB INDUCTION
    Sakhuja, Vinay
    Gundlapalli, Srikanth
    Rathi, Manish
    Jha, Vivekanand
    Kohli, H. S.
    Sharma, Ashish
    Minz, M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 513 - 513
  • [2] Steroid-free immunosuppression regimen in live-donor pediatric renal transplant recipients
    Garcia, C. Druck
    Bittencourt, V. Barros
    Malheiros, D.
    Antonello, J.
    Bonatto, H.
    Proenco, A.
    Rohden, R.
    Garcia, V. Duro
    PEDIATRIC NEPHROLOGY, 2008, 23 (09) : 1684 - 1684
  • [3] Steroid-avoidance immunosuppression regimen in live-donor renal allotransplant recipients: A prospective, randomized, controlled study
    Nematalla, Ahmed H.
    Bakr, Mohmed A.
    Gheith, Osama A.
    ELAgroudy, Amgad E.
    ELShahawy, EL-Metwally
    AGhoneim, Mohamed
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2007, 5 (02) : 673 - 679
  • [4] Randomised study of steroid free immunosuppression with basiliximab induction vs standard triple drug immunosuppression in adult live donor liver transplantation (LDLT). CTRI/2017/08/009508
    Kathirvel, M.
    Mathew, J. S.
    Binoj, S.
    Mallick, S.
    Varghese, C. T.
    Chandran, B.
    Unnikrishnan, G.
    Menon, R. N.
    Balakrishnan, D.
    Sudheer, O.
    Dhar, P.
    Sudhindran, S.
    TRANSPLANTATION, 2018, 102 : 32 - 32
  • [5] Influence of Induction Therapy Using Basiliximab With Delayed Tacrolimus Administration in Heart Transplant Recipients - Comparison With Standard Tacrolimus-Based Triple Immunosuppression -
    Watanabe, Takuya
    Yanase, Masanobu
    Seguchi, Osamu
    Fujita, Tomoyuki
    Hamasaki, Toshimitsu
    Nakajima, Seiko
    Kuroda, Kensuke
    Kumai, Yuto
    Toda, Koichi
    Iwasaki, Keiichiro
    Kimura, Yuki
    Mochizuki, Hiroki
    Anegawa, Eiji
    Sujino, Yasumori
    Yagi, Nobuichiro
    Yoshitake, Koichi
    Wada, Kyoichi
    Matsuda, Sachi
    Takenaka, Hiromi
    Ikura, Megumi
    Nakagita, Kazuki
    Yajima, Shin
    Matsumoto, Yorihiko
    Tadokoro, Naoki
    Kakuta, Takashi
    Fukushima, Satsuki
    Ishibashi-Ueda, Hatsue
    Kobayashi, Junjiro
    Fukushima, Norihide
    CIRCULATION JOURNAL, 2020, 84 (12) : 2212 - 2223
  • [6] COMPARISON OF BASILIXIMAB VS NO INDUCTION ON 12-MONTHS RENAL FUNCTION IN KIDNEY TRANSPLANT RECIPIENTS IN THE TACROLIMUS ERA
    Lys, Zdenek
    Valkovsky, Ivo
    Havranek, Pavel
    Dedochova, Jarmila
    Polaskova, Jana
    Vaclavik, Jan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
  • [7] COMPARISON OF BASILIXIMAB VS NO INDUCTION ON 24-MONTHS RENAL FUNCTION IN KIDNEY TRANSPLANT RECIPIENTS IN THE TACROLIMUS ERA
    Lys, Zdenek
    Dedochova, Jarmila
    Polaskova, Jana
    Valkovsky, Ivo
    Havranek, Pavel
    Vaclavik, Jan
    TRANSPLANT INTERNATIONAL, 2021, 34 : 256 - 256
  • [8] Basiliximab induction alone vs a dual ATG-basiliximab approach in first live-donor non-sensitized kidney transplant recipients with low HLA matching
    Hod, Tammy
    Levinger, Shmuel
    Askenasy, Enosh
    Siman-Tov, Maya
    Davidov, Yana
    Ghinea, Ronen
    Pencovich, Niv
    Nachmani, Ido
    Mor, Eytan
    CLINICAL KIDNEY JOURNAL, 2024, 17 (09)
  • [9] Basiliximab vs. No Induction Therapy in Kidney Transplant Recipients with a Low Immunological Risk Profile Receiving Tacrolimus/Mycophenolate/Steroids Maintenance Immunosuppression
    Lacave, Florian
    de Terwangne, Christophe
    Darius, Tom
    Buemi, Antoine
    Mourad, Michel
    France, Yannick
    Coelho, Joana Cardoso
    Fernandes, Guillaume
    Goffin, Eric
    Devresse, Arnaud
    Kanaan, Nada
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (20)
  • [10] REJECTION EPISODES, VIRAEMIA PREVALENCE AND IMMUNOSUPPRESSION SWITCHES WITHIN THE FIRST YEAR FOR PAEDIATRIC RENAL TRANSPLANT RECIPIENTS COMMENCED ON IMMUNOSUPPRESSION PROTOCOL OF AZATHIOPRINE, TACROLIMUS AND STEROIDS WITH BASILIXIMAB INDUCTION.
    Arslan, Zainab
    Ware, Nick
    Walsh, Granule
    Jones, Helen
    PEDIATRIC NEPHROLOGY, 2018, 33 (10) : 1963 - 1964
12